News Summary

Glen Ventures, a new venture capital firm focused on healthtech, has secured a $5 million CAD investment from the Eurêka investment fund, a Québec government-backed initiative. This funding is aimed at supporting pre-seed healthtech startups in Quebec, a sector that has struggled to find lead investors due to the province’s generalist and deep-tech-focused VC landscape. Glen Ventures, affiliated with the McGill University Health Centre, plans to use the funds to drive product development and go-to-market strategies for early-stage healthtech companies. The firm aims to invest in startups with intellectual property stemming from Quebec public research institutions and is committed to connecting founders with potential investors to prepare them for Series A rounds. This initiative is part of the province’s five-year innovation strategy, with the Eurêka fund serving as a bridge between academic research and industry to spur innovation.